These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 11041456)

  • 1. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA-4 in Japanese patients.
    Akamizu T; Sale MM; Rich SS; Hiratani H; Noh JY; Kanamoto N; Saijo M; Miyamoto Y; Saito Y; Nakao K; Bowden DW
    Thyroid; 2000 Oct; 10(10):851-8. PubMed ID: 11081251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases.
    Ban Y; Tomer Y
    Autoimmunity; 2003; 36(6-7):367-79. PubMed ID: 14669944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations.
    Bednarczuk T; Hiromatsu Y; Fukutani T; Jazdzewski K; Miskiewicz P; Osikowska M; Nauman J
    Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic susceptibility in thyroid autoimmunity.
    Ban Y; Tomer Y
    Pediatr Endocrinol Rev; 2005 Sep; 3(1):20-32. PubMed ID: 16369210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
    Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
    Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.
    Sakai K; Shirasawa S; Ishikawa N; Ito K; Tamai H; Kuma K; Akamizu T; Tanimura M; Furugaki K; Yamamoto K; Sasazuki T
    Hum Mol Genet; 2001 Jun; 10(13):1379-86. PubMed ID: 11440990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
    Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
    Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Davies TF
    Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
    Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
    Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q; Yang YM; Lv XY
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.
    Jacobson EM; Tomer Y
    J Autoimmun; 2007; 28(2-3):85-98. PubMed ID: 17369021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CTLA4 region as a general autoimmunity factor: an extended pedigree provides evidence for synergy with the HLA locus in the etiology of type 1 diabetes mellitus, Hashimoto's thyroiditis and Graves' disease.
    Einarsdottir E; Söderström I; Löfgren-Burström A; Haraldsson S; Nilsson-Ardnor S; Penha-Goncalves C; Lind L; Holmgren G; Holmberg M; Asplund K; Holmberg D
    Eur J Hum Genet; 2003 Jan; 11(1):81-4. PubMed ID: 12529710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population.
    Ban Y; Tozaki T; Taniyama M; Tomita M; Ban Y
    Autoimmunity; 2005 Mar; 38(2):151-3. PubMed ID: 16040335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
    Imrie H; Vaidya B; Perros P; Kelly WF; Toft AD; Young ET; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2001 Feb; 86(2):626-30. PubMed ID: 11158020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
    Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.
    Kotsa K; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 1997 May; 46(5):551-4. PubMed ID: 9231050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease.
    Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S
    Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
    Tomer Y; Greenberg DA; Barbesino G; Concepcion E; Davies TF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.